관절내 점성보충 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 원료별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Viscosupplementation Market size was valued at USD 5.38 Billion in 2024 and is poised to grow from USD 5.68 Billion in 2025 to USD 8.71 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The global viscosupplementation market is witnessing consistent growth, primarily driven by the rising incidence of osteoarthritis, especially among the aging population. As demand for non-invasive treatment options escalates, viscosupplementation emerges as a preferred therapy capable of postponing joint surgeries. Advances in hyaluronic acid-based products and a growing preference for minimally invasive procedures further enhance market appeal. Key growth factors include an increased focus on physical mobility and the surging prevalence of sports-related injuries. Nonetheless, market expansion faces challenges such as high treatment costs, reimbursement hurdles, and varying efficacy among patient demographics. Additional alternatives like corticosteroid injections, physical therapy, and oral medications, along with regulatory shifts and regional reimbursement policies, also complicate market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Viscosupplementation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Viscosupplementation Market Segments Analysis

Global Viscosupplementation Market is segmented by Product, Application, Source, End User and region. Based on Product, the market is segmented into Introduction, Single Injection, Three Injection and Five Injection. Based on Application, the market is segmented into Introduction, Knee Osteoarthritis, Hip Osteoarthritis, Shoulder Osteoarthritis and Other Applications. Based on Source, the market is segmented into Introduction, Animal Source and Non-Animal Source. Based on End User, the market is segmented into Introduction, Hospitals, Orthopedic Clinics/Ambulatory Surgical Centers (ASCS), Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Viscosupplementation Market

The rising incidence of osteoarthritis, particularly among older adults, significantly propels the growth of the global viscosupplementation market. As individuals age, they face heightened risks of joint deterioration, leading to a greater demand for non-surgical pain relief options, such as hyaluronic acid injections. This trend towards minimally invasive therapies, preferred over more invasive procedures like total joint replacements, fosters expansion in both advanced and emerging markets. Consequently, the push for effective alternatives to manage joint pain not only addresses the needs of the aging population but also encourages innovation and investment within the viscosupplementation sector.

Restraints in the Global Viscosupplementation Market

The global viscosupplementation market faces significant restraints due to the high costs associated with advanced or branded hyaluronic acid formulations used in these procedures. Additionally, inconsistent or limited reimbursement policies in various regions can deter patients from pursuing this treatment option. This financial burden on healthcare systems, coupled with out-of-pocket expenses for patients, poses a substantial barrier to broader acceptance of viscosupplementation, particularly in markets where price sensitivity is a critical concern. As a result, the overall growth and adoption of these procedures can be hindered, limiting their availability and accessibility to those in need.

Market Trends of the Global Viscosupplementation Market

The Global Viscosupplementation market is witnessing a significant shift towards single-injection and long-acting formulations, driven by a growing preference for convenient treatment options among patients and healthcare providers. Single-injection hyaluronic acid therapies streamline the treatment process, reducing clinic time and procedural risks, thus enhancing patient satisfaction. Simultaneously, the introduction of long-acting formulations offers extended joint lubrication and sustained pain relief, leading to improved patient compliance and clinical outcomes. This trend aligns with broader changes in outpatient care, highlighting a cost-effective approach to osteoarthritis management while fostering an environment conducive to innovative treatment solutions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Viscosupplementation Market Size by Product & CAGR (2026-2033)

• Market Overview
• Introduction
• Single Injection
• Three Injection
• Five Injection

Global Viscosupplementation Market Size by Application & CAGR (2026-2033)

• Market Overview
• Introduction
• Knee Osteoarthritis
• Hip Osteoarthritis
• Shoulder Osteoarthritis
• Other Applications

Global Viscosupplementation Market Size by Source & CAGR (2026-2033)

• Market Overview
• Introduction
• Animal Source
• Non-Animal Source

Global Viscosupplementation Market Size by End User & CAGR (2026-2033)

• Market Overview
• Introduction
• Hospitals
• Orthopedic Clinics/Ambulatory Surgical Centers (ASCS)
• Retail Pharmacies
• Online Pharmacies

Global Viscosupplementation Market Size & CAGR (2026-2033)

• North America (Product, Application, Source, End User)
  • US
  • Canada
• Europe (Product, Application, Source, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, Source, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, Source, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, Source, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anika Therapeutics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SEIKAGAKU CORPORATION (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fidia Farmaceutici S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avanos Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LG Chem, Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBSA Institut Biochimique SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifecore Biomedical, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aptissen SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chugai Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kolon TissueGene, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TRB CHEMEDICA SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations